Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Abstract
Several new chromosomal translocations resulting in driver fusion mutations have recently been discovered in non-small-cell lung cancer. The driver mutational patterns in pulmonary mucinous adenocarcinoma, a rare subtype of non-small-cell lung cancer, have not been well studied. A single-institute cohort study in Taiwan was performed to determine the mutations of epidermal growth factor receptor (EGFR), Kirsten rat sarcoma viral oncogene homolog (KRAS), fusions of anaplastic lymphoma kinase (ALK), c-ros oncogene 1 (ROS1), and neuregulin 1 (NRG1) in patients diagnosed with pulmonary mucinous adenocarcinoma. We also examined NRG1 translocation in patients diagnosed as adenocarcinoma of other subtypes with wild-type EGFR, KRAS, ALK, and ROS1 genes. Surgical or biopsy specimens were collected from 13 patients with mucinous adenocarcinoma. Using the direct RNA sequencing method, we discovered a rare CD74-NRG1 fusion (8 %), an echinoderm microtubule-associated protein like 4 (EML4)-ALK fusion (17 %), and three KRAS mutations (25 %). No EGFR mutations or ROS1 rearrangements were detected. The rare CD74-NRG1 fusion positive patient presented with uncommon radiological features. We did not detect any CD74-NRG1 fusion in the 109 adenocarcinoma of other subtypes, which were all negative for EGFR, KRAS, ALK, and ROS1. The CD74-NRG1 fusion mutation is rare and may be exclusively present in patients with pulmonary mucinous adenocarcinoma. Patients harboring CD74-NRG1 positive tumors may present with uncommon imaging features.
Fernandez-Cuesta,
CD74-NRG1 fusions in lung adenocarcinoma.
2014, Pubmed
Fernandez-Cuesta,
CD74-NRG1 fusions in lung adenocarcinoma.
2014,
Pubmed
Finberg,
Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.
2007,
Pubmed
Hata,
Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.
2010,
Pubmed
Ichinokawa,
Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation.
2013,
Pubmed
Kakegawa,
Clinicopathological features of lung adenocarcinoma with KRAS mutations.
2011,
Pubmed
Kohno,
KIF5B-RET fusions in lung adenocarcinoma.
2012,
Pubmed
Li,
ALK-rearranged lung cancer in Chinese: a comprehensive assessment of clinicopathology, IHC, FISH and RT-PCR.
2013,
Pubmed
Li,
Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
2013,
Pubmed
Pao,
Chipping away at the lung cancer genome.
2012,
Pubmed
Sartori,
EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.
2009,
Pubmed
Shim,
FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation.
2010,
Pubmed
Soda,
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.
2007,
Pubmed
,
Echinobase
Takeuchi,
RET, ROS1 and ALK fusions in lung cancer.
2012,
Pubmed
Tam,
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
2006,
Pubmed
Travis,
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.
2011,
Pubmed
Tsai,
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy.
2013,
Pubmed
Vaishnavi,
Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.
2013,
Pubmed
Wu,
Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma.
2008,
Pubmed
Zhang,
Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis.
2012,
Pubmed
